1Astorgues-Xerri L, Riveiro ME, Tijeras- Rabailand A, et al. Unraveling galectin- 1 as a novel therapeulic target for cancer[J]. Cancer Treat Rev,2014,40(2):307- 319.
2He XJ, Tao HQ, Hu ZM, et al. Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1[J].Cancer Sci,2014,105(11) :1 402- 1 410.
3Wu MH, Hong TM, Cheng HW, et al. Galectin -1-mediated tumor invasion and tnetastasis, up regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons [J]. Mol Cancer Res,2009,7(3) :311-318.
4Banh A, Zhang J, Cao H, et al. Tumor galectin-1 mediates tumor growth and metastasis through regulation of T- cell apoptosis[J]. Cancer Res, 2011,71(13) :4 423-4 431.
5Xibille-Friedmann D, Bustos RC, Rojas-Serrano J, et al. A decrease in galeetin-1 (Gal-1) levels correlates with an increase in anti- Gal- 1 antibodies at the synovial level in patients with rheumatoid arthritis [J]. Scand J Rheumatol, 2013,42(2) : 102- 107.
6Kim HJ, Jeon HK, Cho YJ, et al. High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion[J]. Eur J Cancer, 2012,48(12):1 914-1 921.
7Ye J, Liu H, Hu Y, et al. The clinical implication of tumoral Gal-1 expression in laryngeal squamous cell carcinomas[J]. Clin Transl Oncol, 2013,15 (8), 608- 618.
8Camby I, Le MM, Lefranc F, et al. Galectin-1: a small protein with major functions [J]. Glycobiology, 2006, 16 (11): 137R-157R.
9Cedeno-Laurent F, Dimitroff CJ. Galectin-1 research in T cell immunity: past, present and future[J]. Clin Immunol, 2012,142(2) : 107-116.
10Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol, 2007,114(2):97-109.
